MX2007010403A - Proceso de purificacion. - Google Patents

Proceso de purificacion.

Info

Publication number
MX2007010403A
MX2007010403A MX2007010403A MX2007010403A MX2007010403A MX 2007010403 A MX2007010403 A MX 2007010403A MX 2007010403 A MX2007010403 A MX 2007010403A MX 2007010403 A MX2007010403 A MX 2007010403A MX 2007010403 A MX2007010403 A MX 2007010403A
Authority
MX
Mexico
Prior art keywords
formula
detection
acid addition
free base
addition salt
Prior art date
Application number
MX2007010403A
Other languages
English (en)
Spanish (es)
Inventor
Gerhard Penn
Ulrich Beutler
Peter Funfschilling
Alfons Roth
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2007010403A publication Critical patent/MX2007010403A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/84—Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2007010403A 2005-02-25 2006-02-23 Proceso de purificacion. MX2007010403A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0503942.5A GB0503942D0 (en) 2005-02-25 2005-02-25 Purification process
PCT/EP2006/001656 WO2006089746A1 (en) 2005-02-25 2006-02-23 Purification process

Publications (1)

Publication Number Publication Date
MX2007010403A true MX2007010403A (es) 2008-01-14

Family

ID=34430229

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007010403A MX2007010403A (es) 2005-02-25 2006-02-23 Proceso de purificacion.

Country Status (11)

Country Link
EP (1) EP1856026A1 (ru)
JP (2) JP2008531513A (ru)
KR (1) KR20070106739A (ru)
CN (1) CN101124195B (ru)
AU (2) AU2006218076B2 (ru)
BR (1) BRPI0608368A2 (ru)
CA (1) CA2598846A1 (ru)
GB (1) GB0503942D0 (ru)
MX (1) MX2007010403A (ru)
RU (1) RU2444511C2 (ru)
WO (1) WO2006089746A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011520471A (ja) * 2008-05-23 2011-07-21 サイバス オイルズ，エルエルシー 酵母を使用したスクアレンの生成
CN104725240B (zh) * 2015-02-12 2017-05-24 吉林修正药业新药开发有限公司 一种盐酸特比萘芬z型异构体的制备方法
CN105738522A (zh) * 2016-02-29 2016-07-06 中国烟草总公司广东省公司 基于高效液相色谱检测烟叶中所含角鲨烯的方法
CN105699552A (zh) * 2016-02-29 2016-06-22 广州医科大学附属第三医院 基于高效液相色谱法检测卷烟烟气所含角鲨烯的样品液净化处理方法
CN105738524A (zh) * 2016-02-29 2016-07-06 中国烟草总公司广东省公司 一种烟叶中所含角鲨烯的高效液相色谱检测方法
CN105738535A (zh) * 2016-02-29 2016-07-06 中国烟草总公司广东省公司 基于高效液相色谱法检测卷烟烟气所含角鲨烯的样品液制备方法
CN105758954A (zh) * 2016-02-29 2016-07-13 中国烟草总公司广东省公司 卷烟烟气中角鲨烯的检测方法
CN105699531A (zh) * 2016-02-29 2016-06-22 中国烟草总公司广东省公司 一种基于高效液相色谱法检测卷烟烟气所含角鲨烯的样品液净化处理方法
CN105738525A (zh) * 2016-02-29 2016-07-06 中国烟草总公司广东省公司 烟叶中所含角鲨烯的高效液相色谱检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3069633D1 (en) * 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
SU1507740A1 (ru) * 1987-04-23 1989-09-15 Харьковский Отдел Водного Хозяйства Промпредприятий Всесоюзного Научно-Исследовательского Института Водоснабжения, Канализации, Гидротехнических Сооружений И Инженерной Гидрогеологии "Водгео" Способ очистки воды от органических примесей
SU1564513A1 (ru) * 1988-06-27 1990-05-15 Главная геофизическая обсерватория им.А.И.Воейкова Способ контрол степени очистки газа от вредных загр зн ющих веществ и устройство дл его осуществлени
JP3116364B2 (ja) * 1989-10-02 2000-12-11 萬有製薬株式会社 エンイン誘導体の製造法
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
ES2203190T3 (es) * 1999-10-22 2004-04-01 Richter Gedeon Vegyeszeti Gyar R.T. Procedimiento para la preparacion de (e)-n-metil-n-(1-naftil-metil)-6,6-dimetil-hept-2-en-4-inil-1-amina.
GB0103046D0 (en) * 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
ITMI20010430A1 (it) * 2001-03-02 2002-09-02 Dinamite Dipharma S P A In For Metodo per la sintesi di terbinafina
GB0320312D0 (en) * 2003-08-29 2003-10-01 Novartis Ag Purification process
US20050197512A1 (en) * 2003-08-29 2005-09-08 Ulrich Beutler Purification process

Also Published As

Publication number Publication date
RU2007135279A (ru) 2009-03-27
WO2006089746A1 (en) 2006-08-31
CN101124195B (zh) 2012-05-30
GB0503942D0 (en) 2005-04-06
BRPI0608368A2 (pt) 2010-01-05
EP1856026A1 (en) 2007-11-21
KR20070106739A (ko) 2007-11-05
AU2011200338A1 (en) 2011-02-17
AU2006218076B2 (en) 2010-10-28
JP2012176960A (ja) 2012-09-13
CN101124195A (zh) 2008-02-13
CA2598846A1 (en) 2006-08-31
RU2444511C2 (ru) 2012-03-10
JP2008531513A (ja) 2008-08-14
AU2006218076A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
MX2007010403A (es) Proceso de purificacion.
JP2009541553A5 (ru)
DE502005005073D1 (de) Verfahren zur destillativen Trennung von wässrigen Aminlösungen
DE502004004307D1 (de) Verfahren zur herstellung von gereinigten 1,3-substituierten imidazoliumsalzen
WO2008131856A3 (de) Verfahren zur rückgewinnung von ruthenium aus einem rutheniumhaltigen geträgerten katalysatormaterial
PT2024279E (pt) Processo de separação do cloro do produto gasoso de um processo de oxidação de hcl
MX2010005124A (es) Procedimiento de preparacion de compuestos morfinicos.
JP2008531513A5 (ru)
NO20065942L (no) Gjenvinning av 2,6-naftalendiakarboksylsyre (2,6-NDA) inneholdt i polyetylennaftalat i en fremgangsmate for a fremstille diestere
MA29690B1 (fr) Procede de preparation de la 4beta-amino-4'-demethyl-4-desoxypodophyllotoxine
ATE541942T1 (de) Verfahren zur rückgewinnung von shikimisäure
TNSN06066A1 (en) Process for the purification of terbinafine
MY128541A (en) Distillative workup of tetrahydrofuran
JP2009511622A (ja) ヘキサメチレンジアミン及びアミノカプロニトリルの製造方法
JPWO2014178309A1 (ja) ジメチルスルホキシドの精製法
WO2009088255A3 (en) Method for preparing antigen effective for preventing anthrax infection
DE602004015310D1 (de) Verfahren zur herstellung von mycophenolatmofetil
ATE364591T1 (de) Verfahren zur vermeidung von korrosion
FR2922207B1 (fr) Procede de purification d'hexamethylene diamine
BR0316179A (pt) Processo para a purificação de caprolactama bruta
DE602006016651D1 (de) Zwischenprodukte und verfahren zur herstellung aromatischer derivate von 1-adamantan
DE602004028830D1 (de) Verfahren zur herstellung von kristallinem dexloxiglumid
ATE536339T1 (de) Verfahren zur rückgewinnung von mineralsäuren bei der herstellung von diphenylmethandiamin
CA2590660A1 (en) Method for purifying (1s)-3-methylamino-1-(2-thienyl)-1-propanol
TH94741A (th) ผลิตภัณฑ์ที่มีกลีเซอรอลดิบเป็นพื้นฐาน กรรมวิธีสำหรับการทำให้ผลิตภัณฑ์บริสุทธิ์และการใช้ผลิตภัณฑ์ในการผลิตไดคลอโรโพรพานอล

Legal Events

Date Code Title Description
FA Abandonment or withdrawal